Supra is a medical device startup that is developing a groundbreaking in-office injector for the suprachoroidal space, offering a simple way to deliver drugs effectively, efficiently, and safely. Its innovative injector enables ophthalmologists to perform in-office Suprachoroidal drug administration, for safe, effective, and long-lasting treatments for various eye conditions. The suprachoroidal approach is a novel drug delivery route that improves outcomes for a wide variety of treatments and paves the way for groundbreaking gene therapies. The injection system makes this approach easily applicable, delivering better vision and quality of life for patients.